Current management and perspectives in the treatment of ventricular assist device-specific infections.

Al Shakaki, Mosab;Rotering, Heinrich;Mastrobuoni, Stefano;Welp, Henryk;Dell'Aquila, Angelo M
(2019) Journal of Thoracic Disease — Vol. 11, n° 5, p. 2111-2116 (2019)

Files

2019_Al_Shakaki_J_Thorac_Dis.pdf
  • Open Access
  • Adobe PDF
  • 452.63 KB
Download

Details

Authors
  • Al Shakaki, Mosab
    Author
  • Rotering, Heinrich
    Author
  • Mastrobuoni, StefanoUCLouvain
    Author
  • Welp, Henryk
    Author
  • Dell'Aquila, Angelo M
    Author
Abstract
Occurrence of ventricular assist device (VAD)-specific infections is a serious complication that can jeopardize on the long run the effectiveness of VAD therapy. In the light of ongoing shortage of organ available for heart transplantation there will be in the next future an increase necessity of conservative strategies. A multidisciplinary approach including cardiac surgeons, cardiologist, infectious disease (ID) consultant and nuclear medicine physicians should be the first step for the diagnosis and treatment of VAD-specific infections. Early detection of infections and consequently early treatment with innovative strategies may help physicians to improve outcomes.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Al Shakaki, M., Rotering, H., Mastrobuoni, S., Welp, H., & Dell’Aquila, A. M. (2019). Current management and perspectives in the treatment of ventricular assist device-specific infections. Journal of Thoracic Disease, 11(5), 2111-2116. https://doi.org/10.21037/jtd.2019.05.23 (Original work published 2019)